Are nurses using catheter lock solutions correctly? new study investigates
NCT ID NCT07259421
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will survey how taurolidine lock solutions are actually given to patients with a PICC line who need nutrition through a vein. Researchers will check if nurses follow the recommended steps and compare what is prescribed to what is administered. The goal is to spot any gaps in practice and improve safety for these patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- taurolidine lock solution
- What this could lead to
- If this study reveals common mistakes, it could lead to better training and safer use of taurolidine lock solutions, reducing infections in PICC patients.
- What could go wrong
- This is a small, observational survey (45 participants) at a single hospital. It only describes current practices, not testing a new treatment, so it won't directly change patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients meeting the inclusion criteria will be recruited consecutively over a three-month period to minimize the risk of selection bias.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient who has undergone PICC placement in the vascular access unit with an indication for parenteral nutrition supplementation. * Patient not opposed to participating in this research. Exclusion Criteria: * Patient not speaking French * Patient under guardianship or conservatorship * Patient with major neurocognitive disorders * Patient with severe hearing impairment * Patient who do not have a telephone
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Taurolidine lock solution are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.